Pale Fire Capital SE’s Prelude Therapeutics PRLD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-31,481	Closed	-$149K	–	59
2024 Q1	$149K	Sell	31,481 -32,100	-50%	-$152K	0.02%	39
2023 Q4	$271K	Buy	63,581 +32,800	+107%	+$140K	0.04%	46
2023 Q3	$95.1K	Buy	+30,781	New	+$95.1K	0.01%	51